Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference ...Middle East

PONTE VEDRA, Fla., Oct. 9, 2023 /PRNewswire/ -- Cadrenal Therapeutics, Inc., (Nasdaq: CVKD), a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes and deaths due to blood clots in...

Hence then, the article about cadrenal therapeutics to participate in the lytham partners fall 2023 investor conference was published today ( Monday 09/10/2023 - 11:24 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Cadrenal Therapeutics to Participate in the Lytham Partners Fall 2023 Investor Conference )

Also on site :

• Ground stop issued at O'Hare amid snowfall and icy conditions
• What Is Situs Inversus? Inside Catherine O'Hara's Rare Genetic Condition
• Catherine O'Hara Revealed Struggle With Social Anxiety Years Before Her Death